On November 15, 2009
What Genentech and Roche Got From Congress for $15M
Genentech and its parent, Roche (RHHBY.PK), paid lobbyists nearly $15 million in 2008 and 2009 as they urged Congressmen to support the biotech industry’s interests in the healthcare bill and other legislation. The result, chronicled in the New York Times, is that 42 members of the U.S. House of Representatives put similar or identical statements on the record touting the biotech industry’s history of job creation.
0 Comments